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Background: 18F-fluorodeoxyglucose (FDG) accumulates in activated macrophages (Mø). Here, we test the hypotheses that GM-CSF, a clinically 
administered cytokine, augments Mø glycolysis in vitro and enhances imaging of arterial inflammation in vivo.
methods: In vitro experiments were conducted in human and murine Mø. After GM-CSF exposure, mRNA levels were assessed for markers of M1 
and M2 Mø polarization. 2D-Glc uptake was assessed before and after GM-CSF in normoxia and hypoxia. Glycolysis was evaluated at a rate-limiting 
step (Fru-2,6-P2 concentration) and pathway end-product conversion (lactate release). The specificity of findings with glycolysis was assessed with 
uPFK2 silencer RNA (siRNA). In vivo studies in NZW rabbits (n=10) were performed to determine the effect of GM-CSF on FDG uptake in normal vs 
inflamed arteries, using PET imaging. 
results: Upon GM-CSF exposure, dual M1 and M2 polarization was observed, along with increased 2D-Glc uptake and glycolysis, which were 
both attenuated by uPFK2 siRNA (Figure 1). GM-CSF up-regulated glycolysis and 2D-Glc uptake in hypoxia and normoxia. In rabbits, there was a 
73% increase in FDG uptake after GM-CSF (P<0.01), whereas there was no change after saline. In vivo FDG uptake correlated with Mø staining in 
pathological specimens (R=0.75, P<0.01). 
conclusions: GM-CSF augments glycolysis in vitro and increases FDG uptake within inflamed atheroma in vivo. Further studies should explore the 
role of GM-CSF to enhance the detection of inflammatory foci.
 
